Univo Pharmaceuticals Ltd. Logo

Univo Pharmaceuticals Ltd.

Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.

UNVO-M | TA

Overview

Corporate Details

ISIN(s):
IL0010935588
LEI:
Country:
Israel
Address:
30 Haarbaa TEL AVIV-JAFFA, Central District, 6473926 Tel Aviv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Univo Pharmaceuticals Ltd. is a vertically integrated biopharmaceutical company operating in the medical cannabis sector. The company manages the entire value chain, from research, development, and cultivation to the manufacturing and distribution of cannabis-based medical products. By maintaining full control over its processes, Univo aims to develop high-quality solutions to improve patient health and quality of life. The firm has a particular focus on developing treatments for the central nervous system (CNS) and operates a significant distribution network, supplying its products to numerous pharmacies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-10 19:49
Regulatory News Service
ISA informed TASE that the company is a "shell company", the company's securiti…
Hebrew (modern) 81.2 KB
2022-12-18 14:53
Regulatory News Service
Trading in the company's shares has been suspended as of today, on December 28…
Hebrew (modern) 80.0 KB
2022-12-12 11:07
Regulatory News Service
BOND SERIES A-TRADING SUSPENSION FOLLOWING TRUSTEE ANNOUNCEMENT REGARDING IMMED…
Hebrew (modern) 77.4 KB
2022-07-21 19:42
Regulatory News Service
Discontinuation of Market Making, If another market maker will not start to op…
Hebrew (modern) 255.5 KB

Automate Your Workflow. Get a real-time feed of all Univo Pharmaceuticals Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Univo Pharmaceuticals Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Univo Pharmaceuticals Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.